Novo Nordisk’s $1.2 Billion Investment in Denmark Explained
🔹Novo Nordisk has announced a major investment of DKr8.5bn ($1.2bn) to establish a new production facility in Odense,…
New Announcement
Breakthrough in Lung Cancer: Imfinzi’s FDA Approval for Limited-Stage SCLC Patients
AstraZeneca’s (AZ) Imfinzi (durvalumab) has received approval from the US Food and Drug Administration (FDA) for treating adults…
Global Orally Disintegrating Tablet (ODT) Market is expected to exceed more than US$ 26.50 Bn by 2025 at a CAGR of 11.5% in the given forecast period
Global Orally Disintegrating Tablet Market Overview: An Orally Disintegrating Tablet is a drug dosage form available for a…
Metabolic Regulation and Immune Evasion in the Tumor Microenvironment 💊
🔷Tumors exploit metabolic pathways to create an immunosuppressive microenvironment that allows them to evade immune surveillance and thrive.…
Early Signs of Parkinson’s Disease You Shouldn’t Ignore
We recognize the invaluable role that care partners play in the lives of those impacted by Parkinson’s disease…
Lepu biotech: Breakthrough efficacy of PD-1 + EGFR ADC in nasopharyngeal cancer
The European Society for Medical Oncology (ESMO) Asia Congress will be held in Singapore. Lepu Biotech will present…
SALICYLATE IN ASPIRIN: Health benefits and risk
1.Salicylates have been available since the early 1900s. 2.Salicylates have been derived from the willow tree bark. 3.The…
ANTINEOPLASTIC AGENT : A Comprehensive Guide
The antineoplastic agents or anticancer drugs represent a large and diverse class of medications. Cancer is a disease…
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide
Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in…
Ultromics’ breakthrough device for cardiac amyloidosis gets FDA nod
EchoGo® Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an…